ReviewInvestigational new drugs2017

Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents.

Kamil Piska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.